Sean Laaman

Stock Analyst at Morgan Stanley

(3.6)
# 197
Out of 5,271 analysts
2
Total ratings
100.00%
Success rate
73.12%
Average return
Main Sectors:
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
BeiGene
Assumes: Overweight
300
n/a n/a 1 Dec 3, 2024
ResMed
Upgrades: Overweight
169
227.7 -25.78% 1 Oct 27, 2023